Profil
Luc Sterkman is currently the Chief Executive Officer at Caelus Pharmaceuticals BV.
Previously, he worked as a Principal at Kendle International LLC, a Member-Management Board at Dr. Reddy's Research & Development BV, and as the Chief Operating Officer at Newtricious BV.
Postes actifs de Luc Sterkman
| Sociétés | Poste | Début |
|---|---|---|
Caelus Pharmaceuticals BV
Caelus Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology Develops treatments for cardiometabolic diseases based on improving intestinal microbial composition | Directeur Général | - |
Anciens postes connus de Luc Sterkman
| Sociétés | Poste | Fin |
|---|---|---|
Kendle International LLC
Kendle International LLC Miscellaneous Commercial ServicesCommercial Services Provides research and development services to biopharmaceutical companies | Corporate Officer/Principal | - |
Dr. Reddy's Research & Development BV
Dr. Reddy's Research & Development BV Pharmaceuticals: MajorHealth Technology Develops injectable formulations and drugs | Corporate Officer/Principal | - |
Newtricious BV
Newtricious BV Food: Major DiversifiedConsumer Non-Durables Develops active food ingredients for health maintenance | Directeur des opérations | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Kendle International LLC
Kendle International LLC Miscellaneous Commercial ServicesCommercial Services Provides research and development services to biopharmaceutical companies | Commercial Services |
Dr. Reddy's Research & Development BV
Dr. Reddy's Research & Development BV Pharmaceuticals: MajorHealth Technology Develops injectable formulations and drugs | Health Technology |
Newtricious BV
Newtricious BV Food: Major DiversifiedConsumer Non-Durables Develops active food ingredients for health maintenance | Consumer Non-Durables |
Caelus Pharmaceuticals BV
Caelus Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology Develops treatments for cardiometabolic diseases based on improving intestinal microbial composition | Health Technology |
















